Tag Archives: legislation
Rare Diseases Lead to Unique Legislation
Since 1983, pharma and patent organizations have been working together to influence policy aimed at improving the lives of those with rare diseases.
In 1983—with the help of Abbey Meyers and the drive she had to help her son (more on that here)—the Orphan Drug Act was passed to incentivize pharma to step up and play [...]
Posted in Events, Global, Legal Also tagged centric health resources, creating hope act, national organization for rare disorders, policy, Rare Disease Day, TREAT act Leave a comment
US Mid-Term Elections: What It Means for Pharma
Daily News Nugget
US Mid-Term Elections: What it Means for Pharma
Drink up, even if it’s only old wine in new bottles…
Yesterday’s mid-term congressional poll barely changes the stakes for pharma in its pursuit of its US legislative and regulatory agenda. The key message coming out of the results is stalemate on the big issues like [...]
Posted in Op-Ed, Regulatory Also tagged Congress, Democrats, healthcare reform, mid-term elections, regulatory affairs, Republicans, Senate 3 Comments
NICE News or Bad News?
Far from losing its mojo, the UK’s National Institute for Health and Clinical Excellence (NICE) will simply be sharing the stage with a range of new players under NHS reform — none of whom look supportive of the R&D industry.
The big issue for industry in the UK this week is handicapping the future of its [...]
Posted in Europe, Global, Regulatory Also tagged Europe, health economics, NHS, NICE, pricing, Regulatory, UK, value-based pricing Leave a comment

Congress Move Promptly to Finalize FDA User Fees